Tower Research Capital LLC (TRC) - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 121 filers reported holding ANI PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 3.91 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$16,605
-24.8%
286
-30.2%
0.00%0.0%
Q2 2023$22,070
+104995.2%
410
-20.7%
0.00%0.0%
Q1 2023$21
+75.0%
517
+78.3%
0.00%
Q4 2022$12
-100.0%
290
-89.7%
0.00%
-100.0%
Q3 2022$91,000
+600.0%
2,813
+540.8%
0.00%
Q2 2022$13,000
+116.7%
439
+108.1%
0.00%
Q1 2022$6,000
-53.8%
211
-26.0%
0.00%
Q4 2021$13,000
-58.1%
285
-69.2%
0.00%
-100.0%
Q3 2021$31,000
-46.6%
924
-44.2%
0.00%
-50.0%
Q2 2021$58,000
+205.3%
1,655
+217.7%
0.00%
Q1 2021$19,000
-38.7%
521
-51.2%
0.00%
-100.0%
Q4 2020$31,000
-87.4%
1,068
-87.8%
0.00%
-66.7%
Q3 2020$246,000
+382.4%
8,733
+445.5%
0.00%
+50.0%
Q2 2020$51,000
+59.4%
1,601
+315.8%
0.00%0.0%
Q2 2019$32,000
+190.9%
385
+53.4%
0.00%
+100.0%
Q4 2018$11,000
-59.3%
251
-50.9%
0.00%
-50.0%
Q3 2017$27,000
-10.0%
511
-15.7%
0.00%
-33.3%
Q1 2017$30,000
+500.0%
606
+630.1%
0.00%
+200.0%
Q4 2016$5,000
-90.9%
83
-89.9%
0.00%
-80.0%
Q3 2016$55,000
+323.1%
822
+267.0%
0.01%
+400.0%
Q2 2016$13,000
-88.0%
224
-91.8%
0.00%
-90.0%
Q3 2015$108,0002,7380.01%
Q4 2014$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q2 2014$183,000
+185.9%
5,313
+158.9%
0.02%
+200.0%
Q1 2014$64,000
+3100.0%
2,052
+1931.7%
0.01%
Q4 2013$2,000
+100.0%
101
+40.3%
0.00%
Q3 2013$1,000720.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 272,801$15,838,8267.50%
Global Alpha Capital Management Ltd. 525,528$30,512,1563.06%
Rubric Capital Management LP 847,011$49,177,4591.84%
Ranger Investment Management 426,848$24,782,7951.64%
Parkman Healthcare Partners LLC 111,802$6,491,2241.19%
MARATHON CAPITAL MANAGEMENT 71,670$4,161,1601.05%
Mesirow Financial Investment Management, Inc. 3,862$224,2280.98%
Deep Track Capital, LP 400,000$23,224,0000.90%
1492 Capital Management LLC 18,178$1,055,4150.68%
Phocas Financial Corp. 75,213$4,367,0000.64%
View complete list of ANI PHARMACEUTICALS INC shareholders